Discover the complete record of transactions filed by He Wei-Wu, Chairman & CEO. Officer active across 1 companies, notably CASI Pharmaceuticals, Inc.. Cumulatively, 5 filings have been published. Total volume traded: €1.1m. The latest transaction was filed on 13 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations
He Wei-Wu is the Chairman and CEO of CASI Pharmaceuticals, Inc., a company focused on developing innovative treatments for serious diseases. Under his leadership, the company is committed to providing high-quality therapeutic solutions and improving patients' lives. He Wei-Wu plays a key role in the company's strategy and vision, overseeing operations and guiding the team towards achieving growth and innovation objectives.